Humana Inc. (NYSE:HUM) – Equities researchers at Jefferies Group raised their FY2016 earnings per share estimates for Humana in a note issued to investors on Thursday. Jefferies Group analyst D. Windley now anticipates that the brokerage will earn $9.51 per share for the year, up from their previous forecast of $9.28. Jefferies Group currently has a “Buy” rating and a $217.00 target price on the stock. Jefferies Group also issued estimates for Humana’s FY2017 earnings at $11.40 EPS and FY2018 earnings at $11.51 EPS.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The company had revenue of $14 billion for the quarter, compared to analysts’ expectations of $13.59 billion. During the same period last year, the firm earned $1.67 earnings per share. The business’s revenue for the quarter was up 2.0% on a year-over-year basis.

Earnings History and Estimates for Humana (NYSE:HUM)

Several other equities research analysts also recently commented on HUM. Leerink Swann reissued an “outperform” rating on shares of Humana in a research report on Tuesday, June 21st. Wolfe Research started coverage on shares of Humana in a research report on Tuesday, June 28th. They set a “market perform” rating and a $244.00 target price for the company. Credit Suisse Group AG reissued a “hold” rating on shares of Humana in a research report on Tuesday, June 28th. JPMorgan Chase & Co. downgraded shares of Humana from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $196.00 to $150.00 in a research report on Friday, July 8th. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a research report on Saturday, July 9th. Seven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Humana presently has a consensus rating of “Buy” and a consensus target price of $200.50.

Humana (NYSE:HUM) opened at 170.82 on Monday. The stock’s 50 day moving average is $175.94 and its 200 day moving average is $175.74. Humana has a one year low of $150.00 and a one year high of $191.65. The company has a market capitalization of $25.46 billion, a PE ratio of 26.24 and a beta of 0.90.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be given a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 0.68%. The ex-dividend date is Tuesday, October 11th. Humana’s dividend payout ratio (DPR) is currently 18.18%.

Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in Humana by 2.5% in the second quarter. Vanguard Group Inc. now owns 8,964,492 shares of the insurance provider’s stock valued at $1,612,532,000 after buying an additional 219,311 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in Humana by 3.2% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 3,908,027 shares of the insurance provider’s stock valued at $702,976,000 after buying an additional 120,720 shares during the period. Arrowgrass Capital Partners US LP raised its stake in Humana by 1.8% in the first quarter. Arrowgrass Capital Partners US LP now owns 2,878,848 shares of the insurance provider’s stock valued at $526,685,000 after buying an additional 51,267 shares during the period. Evercore Trust Company N.A. raised its stake in Humana by 3.0% in the second quarter. Evercore Trust Company N.A. now owns 2,570,366 shares of the insurance provider’s stock valued at $462,357,000 after buying an additional 75,126 shares during the period. Finally, BlackRock Fund Advisors raised its stake in Humana by 2.5% in the second quarter. BlackRock Fund Advisors now owns 2,074,281 shares of the insurance provider’s stock valued at $373,122,000 after buying an additional 51,378 shares during the period. 93.27% of the stock is currently owned by institutional investors.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.